General Information:

Id: 2,868 (click here to show other Interactions for entry)
Diseases: Diabetes mellitus, type II - [OMIM]
Insulin resistance
Mus musculus
Reference: Foretz M et al.(2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120: 2355-2369 [PMID: 20577053]

Interaction Information:

Comment Metformin suppresses hepatic glucose production in the absence of AMPK catalytic subunits and in the absence of LKB1.
Formal Description
Interaction-ID: 26442

drug/chemical compound


decreases_activity of



in liver; independent of AMPK catalytic chains and independent of STK11 (LKB1)
Drugbank entries Show/Hide entries for Metformin